Genetic Analysis of SCN11A , SCN10A , and SCN9A in Familial Episodic Pain Syndrome (FEPS) in Japan and Proposal of Clinical Diagnostic Criteria

• Published in: International journal of molecular sciences 2024-07, Vol.25 (13), p.6832
• Main Authors: Noguchi, Atsuko, Tezuka, Tohru, Okuda, Hiroko, Kobayashi, Hatasu, Harada, Kouji H, Yoshida, Takeshi, Akioka, Shinji, Wada, Keiko, Takeya, Aya, Kabata-Murasawa, Risako, Kondo, Daiki, Ishikawa, Ken, Asano, Takeshi, Fujiwara, Michimasa, Hishikawa, Nozomi, Mizukami, Tomoyuki, Hitomi, Toshiaki, Youssefian, Shohab, Nagai, Yoshihiro, Tanaka, Manabu, Eto, Kaoru, Shiraishi, Hideaki, Amaya, Fumimasa, Koizumi, Akio, Takahashi, Tsutomu
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Child; Child, Preschool; Congenital diseases; Diagnostic equipment (Medical); Disease; Female; Genetic aspects; Genetic Predisposition to Disease; Genetic research; Genetic testing; Genetic Testing - methods; Humans; Japan - epidemiology; Male; Medical colleges; Migraine; Mutation; NAV1.7 Voltage-Gated Sodium Channel - genetics; NAV1.8 Voltage-Gated Sodium Channel - genetics; NAV1.9 Voltage-Gated Sodium Channel - genetics; Nervous system; Pain; Patients; Recruitment; Rectum - abnormalities; Young Adult
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25136832

Familial episodic pain syndrome (FEPS) is an early childhood onset disorder of severe episodic limb pain caused mainly by pathogenic variants of , , and , which encode three voltage-gated sodium channels (VGSCs) expressed as key determinants of nociceptor excitability in primary sensory neurons. There may still be many undiagnosed patients with FEPS. A better understanding of the associated pathogenesis, epidemiology, and clinical characteristics is needed to provide appropriate diagnosis and care. For this study, nationwide recruitment of Japanese patients was conducted using provisional clinical diagnostic criteria, followed by genetic testing for , , and . In the cohort of 212 recruited patients, genetic testing revealed that 64 patients (30.2%) harbored pathogenic or likely pathogenic variants of these genes, consisting of 42 (19.8%), 14 (6.60%), and 8 (3.77%) patients with variants of , , and , respectively. Meanwhile, the proportions of patients meeting the tentative clinical criteria were 89.1%, 52.0%, and 54.5% among patients with pathogenic or likely pathogenic variants of each of the three genes, suggesting the validity of these clinical criteria, especially for patients with variants. These clinical diagnostic criteria of FEPS will accelerate the recruitment of patients with underlying pathogenic variants who are unexpectedly prevalent in Japan.